Preclinical Pharmacokinetic Considerations for the Development of Antibody Drug Conjugates
Pharmaceutical Research - United States
doi 10.1007/s11095-014-1584-z
Full Text
Open PDFAbstract
Available in full text
Date
December 2, 2014
Authors
Publisher
Springer Science and Business Media LLC